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Cell metabolism and growth are matched to nutrient availability via the amino-acid-regulated mechanistic
target of rapamycin complex 1 (mTORC1). Transporters have emerged as important amino acid sensors con-
trolling mTOR recruitment and activation at the surface of multiple intracellular compartments. Classically,
this has involved late endosomes and lysosomes, but now, in a recent twist, also the Golgi apparatus.
Here we propose a model in which specific amino acids in assorted compartments activate different
mTORC1 complexes, which may have distinct drug sensitivities and functions. We will discuss the implica-
tions of this for mTORC1 function in health and disease.The Microenvironmental Sensor mTORC1 and
Extracellular Amino Acids
Central to the ability of a cell to adapt to its microenvironment
is mechanistic (formerly mammalian) target of rapamycin
(mTOR) complex 1 (mTORC1), a critical signaling hub, which is
conserved from yeast to humans, regulating both growth and
metabolism (Figure 1A). mTORC1 activity is regulated by a
wide range of signals (reviewed in Dibble and Manning, 2013),
including growth factor signaling (Gao et al., 2002; Inoki et al.,
2002), cellular energy levels via AMP-dependent kinase
(AMPK; Kimura et al., 2003; Inoki et al., 2002), oxygen levels
(Brugarolas et al., 2004), and nutrients, particularly amino acids,
as discussed below.
Genes encoding the key mTORC1 kinase component, mTOR,
were first identified in yeast, as TOR1 and TOR2, through molec-
ular genetic studies, which revealed that they were important tar-
gets of the drug rapamycin (Heitman et al., 1991; Li et al., 2014).
The term mTOR was initially used to refer specifically to TOR’s
mammalian homologs, while nonmammalian TOR was referred
to simply as TOR (Hall, 2013). However, a second definition,
mechanistic TOR, has more recently also been employed in arti-
cles where mammalian, vertebrate, and invertebrate TOR are
considered together, and for simplicity, we will use the latter
term in this review.
Following on from the landmark studies in yeast, mTOR and its
regulation by amino acids were shown to be conserved in mam-
mals (Sabatini et al., 1994; Hara et al., 1998). A combination of
genetic analysis in flies (Gao et al., 2002) and biochemical
work using human cells (Inoki et al., 2002) led to a step change
in thinking: growth factor signaling through PI3-kinase (PI3K)
and Akt was shown to lie upstream of mTORC1 (reviewed in Go-
berdhan and Wilson, 2003), partly, but not exclusively, acting
through the heterotrimeric tuberous sclerosis complex (TSC)
and the monomeric GTPase, Ras homolog enriched in brain
(Rheb).
The best-characterized downstream function of mTORC1 is
the control of mRNA translation. This is achieved via phosphor-
ylation and suppression of the translation initiation inhibitor,
eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), in580 Cell Metabolism 23, April 12, 2016 ª 2016 The Authors. Publishe
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the transcription of a broad range of ribosome biogenesis genes
(Chauvin et al., 2014). However, mTORC1 has numerous other
biochemical targets with important metabolic and cellular func-
tions (Dibble and Manning, 2013; Figure 1A).
This complex metabolic regulatory network, in the classical
paradigm, is represented by a model in which microenviron-
mental inputs funnel through a single mTORC1 hub to give a
wide range of outputs (Figures 1 and 2; Chantranupong et al.,
2015). However, there is increasing awareness that many sig-
naling cascades are controlled at a subcellular level, providing
the flexibility for a more refined response within a single cell.
Several studies of mTORC1 amino-acid-sensing mechanisms
(Thomas et al., 2014; Jewell et al., 2015; Fan et al., 2015), dis-
cussed below, support the existence of a multi-hub model with
at least two forms of mTORC1 (Figure 1B) controlled by amino
acids in different parts of the cell.
What amino acids regulate mTORC1 activity? Pioneering work
in Chinese hamster ovary cells (Hara et al., 1998; Beugnet et al.,
2003) and in the Xenopus oocyte system (Christie et al., 2002)
initially suggested that mTORC1 primarily responds to intracel-
lular levels of leucine. However, subsequent studies have
highlighted sensitivities to other amino acids, such as arginine,
glutamine, and serine (Wang et al., 2015; Jewell et al., 2015;
Fan et al., 2015; Carroll et al., 2016).
Amino acid transporters were initially implicated in mTORC1
regulation as passageways through the plasma membrane,
enabling amino acids to enter cells and activate cytoplasmic
amino acid sensors (Christie et al., 2002; Beugnet et al., 2003).
Consistent with this, the heterodimeric amino acid transporter
CD98, solute-linked carrier (SLC)3A2-SLC7A5 (CD98hc-LAT1),
in combination with a glutamine transporter (SLC1A5), activates
mTORC1 by exchanging leucine for glutamine to increase intra-
cellular leucine levels (Nicklin et al., 2009). Other cell-surface
amino acid transporters, e.g., LAT1 and LAT3 (Wang et al.,
2013) and SLC38A2 (SNAT2; Pinilla et al., 2011), have also
been linked tomTORC1 signaling. The cationic amino acid trans-
porter Slimfast regulates mTORC1 in the adipose-like fat body of
the fly larva, controlling growth of the organism in an endocrined by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. Amino-Acid-Dependent mTORC1 Signaling and Its
Subcellular Control
(A) Microenvironmental inputs, including specific amino acids (labeled 1, 2,
and 3), are integrated by mTORC1 to control metabolic and cellular pathways
that drive cell and organismal growth. CAD, carbamoyl-phosphate synthase 2
(Robitaille et al., 2013); TFEB, transcription factor EB; ULK1, Unc-51-like
autophagy activating kinase 1.
(B) The multi-hub model suggests that functional specificity could be achieved
if distinct inputs regulate more than one mTORC1 signaling hub (labeled A and
B), possibly in specific subcellular regions. Subunits of the mTORC1 complex
are listed below. Note that mTOR-containing mTORC2 includes different
components, such as Rictor, and regulates upstream Akt signaling (reviewed
in Masui et al., 2014).
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unanswered the question of how amino acids are sensed once
inside the cell.
Intracellular Amino Acid Transporters as Regulators of
mTORC1
Genetic screening of a broad range of amino acid transporters in
flies highlighted members of the proton-assisted amino acid
transporter (PAT) or SLC36 family as having a particularly
potent effect in promoting growth in vivo and activatingmTORC1
in a cell-autonomous manner: for example, overexpressing fly
PAT family members in the developing eye or wing increasesorgan growth (Figure 3A; Goberdhan et al., 2005). The ability of
PATs to promote growth increases significantly when growth
rates and mTORC1 signaling in the eye are stimulated by acti-
vated PI3K (Figure 3B; O¨gmundsdo´ttir et al., 2012), a signaling
defect frequently associated with human cancer. Consistent
with this context-dependent effect on growth, the fly PAT,
Pathetic (Path), is more critical for the growth of neurons with
large dendrites than those with small dendrites during normal
development (Lin et al., 2015). Subsequent analysis in HEK293
and MCF-7 breast cancer cells has shown that the two broadly
expressed human PATs, PAT1 and PAT4, are required for
amino-acid-dependent mTORC1 activation and cell prolifera-
tion. These two human PATs can also promote growth in trans-
genic flies in vivo (Heublein et al., 2010).
Before these studies, human PAT1 and PAT2 had already
been shown to transport alanine, glycine, and proline by pro-
ton-coupled secondary active transport (Figure 4B; Boll et al.,
2002; Chen et al., 2003). By comparison, Path expressed in Xen-
opus oocytes (Figure 4B) is not proton assisted and has a much
higher amino acid affinity and lower transport capacity, at least
for alanine. This and the fact that several PATs are concentrated
at the surface of late endosomes and lysosomes (LELs) in many
cell types led to the proposal that they might behave as intracel-
lular amino acid sensors that activate mTORC1 through direct
signaling, acting as so-called ‘‘transceptors’’ (Figure 4A; Go-
berdhan et al., 2005; Goberdhan, 2010). The cell-surface amino
acid transporter SNAT2 (SLC38A2) may also be a transceptor,
since it activates mTORC1 in the presence of the nonmetaboliz-
able amino acid analog Me-AIB (Pinilla et al., 2011).
A key breakthrough in understanding the subcellular control of
mTORC1 by amino acids was the finding that an activated heter-
odimer of Rag GTPases, RagA or RagB together with RagC or
RagD, positively regulates amino-acid-dependent mTORC1
activation (Sancak et al., 2008, 2010). They do this by recruit-
ment of mTOR to the surface of compartments positive for
Rab7 and LAMP2 (lysosome-associated membrane protein 2),
both markers for LELs. This regulatory role of the Rags is
conserved in yeast (Dubouloz et al., 2005), flies (Kim et al.,
2008), and mice (Efeyan et al., 2014), where they are involved
in growth control. However, despite these regulatory parallels,
the yeast Rag homologs, Gtr1 and Gtr2, seem to play a different
role in controlling the subcellular localization of TOR compared
to their mammalian counterparts (Kira et al., 2016) and are not
essential for sustained TORC1 activation (Stracka et al., 2014).
An amino-acid-regulated mTORC1-containing protein super-
complex was identified on LELs, predominantly by biochemical
analyses (Sancak et al., 2010; Zoncu et al., 2011). It linked
the Rags to the LEL membrane via the so-called Ragulator
(LAMTOR) complex (Figure 2; reviewed by Jewell and Guan,
2013; Bar-Peled and Sabatini, 2014; Shimobayashi and Hall,
2016). Proteins regulating or within this complex have been
associated with cancer. For example, components of GATOR1
(Figure 2), which negatively regulates amino acid sensing, act
as tumor suppressors (Bar-Peled et al., 2013), and RagC muta-
tions have recently been linked to follicular lymphoma (Okosun
et al., 2016). Furthermore, amino acid starvation and inactivation
of the Rag heterodimer have been linked to recruitment of the tu-
mor suppressor TSC to LELs (Demetriades et al., 2014, 2016;
Carroll et al., 2016), while another group has reported that TSCCell Metabolism 23, April 12, 2016 581
Figure 2. Model of Amino-Acid-Dependent
mTORC1 Regulation from LELs
Schematic depicts GTP/GDP loading of Rag and
Rheb G proteins and protein-protein interactions
taking place in the presence of amino acids
and growth factors, leading to full activation
of mTORC1 (green). Inhibitory interactions that
happen in the absence of these positive regulators
are shown by dotted crossbars. Multiple sensors
are indicated in red text: the transporters (red wavy
lines) SLC38A9 (SNAT9) and PAT1 (SLC36A1), and
the cytosolic sensors leucyl-tRNA synthetase
(LRS), folliculin and its binding partner (FLCN-
FNIP), Sestrin 2, and CASTOR1 (pink ovals). They
respond to specific amino acid inputs to recruit
and activate mTORC1 on the surface of LELs.
Green arrow indicates the interaction between
PAT1 (SLC36A1) and an mTORC1 supercomplex,
which is less stable than for SLC38A9. TSC
localization on the LEL surface reduces amino-
acid- and/or growth-factor-dependent mTORC1
signaling. Topologically equivalent extracellular
space and intracellular compartment lumens are
indicated in pale blue in this and subsequent fig-
ures. Subunits of mTORC1 regulatory components
are listed below. Schematic adapted from model
presented in Chantranupong et al. (2015).
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non et al., 2014).
But how are amino acids sensed at the LEL surface? Since the
V-ATPase proton pump is part of the LEL-located mTORC1
supercomplex and its interactions are modified by amino acids,
it was proposed as the sensor (Zoncu et al., 2011). The LEL-
localized human PAT1, however, coimmunoprecipitates with
RagC (O¨gmundsdo´ttir et al., 2012); this led to an alternative
model in which the amino acid sensing is carried out by amino
acid transporters based on their ability to bind amino acids.
More recently, SLC38A9, a member of an amino acid trans-
porter family with structural similarities to PATs, was highlighted
as an amino-acid-sensitive regulator of the LEL-located
mTORC1 supercomplex (Figure 2; Wang et al., 2015; Rebsamen
et al., 2015; Jung et al., 2015). Coimmunoprecipitation experi-
ments with different components of this complex consistently
pull down SLC38A9, but not PAT1 or other amino acid trans-582 Cell Metabolism 23, April 12, 2016porters. This strong interaction is depen-
dent on SLC38A9’s cytosolic N-terminal
tail, which has a high affinity for the Rag/
Ragulator complex. As discussed later,
the stability of this interaction may explain
why other transporters were not pulled
down under the conditions employed for
these studies.
SLC38A9 expressed in proteolipo-
somes (Figure 4B; Wang et al., 2015; Re-
bsamen et al., 2015) binds to several
amino acids with different affinities. It
potentially is involved in arginine sensing
(Wang et al., 2015), though it has higher
affinity for other amino acids, such as
glutamine (Rebsamen et al., 2015). Like
some PATs (Goberdhan et al., 2005; Pillai
and Meredith, 2011) and SLC38A2 (Pinillaet al., 2011), SLC38A9 may act as a transceptor because of its
close association with the mTORC1 supercomplex. The high de-
gree of evolutionary conservation in other aspects of mTORC1
regulation, however, suggests that in the absence of a fly
SLC38A9 homolog, this transporter cannot by itself resolve the
amino-acid-sensing puzzle.
Where do transporters like PAT1 and SLC38A9 sense amino
acids? The primary focus has been on the LEL lumen, although
it is also possible that sensing at the cytosolic side could be
involved. Labeled extracellular amino acids rapidly enter the
LELs (Zoncu et al., 2011), probably by a combination of endocy-
tosis and uptake across the LEL membrane. For example,
LAPTM4b (lysosomal-associated transmembrane protein 4b) re-
cruits the heterodimeric transporter SLC7A5-SLC3A2 (LAT1-
CD98hc) to the lysosome, where it can promote leucine uptake
(Milkereit et al., 2015). The LEL luminal microenvironment, there-
fore, provides a complex readout of endocytosed extracellular
Figure 3. Growth Regulation by PATs
(A) Overexpressing one (PAT [) or two (PAT [[)
copies of a PAT amino acid sensor in vivo has
different effects on growth of developing struc-
tures in the fly. Within the postmitotic cells of the
compound eye, ommatidia (unit eyes) and overall
eye size progressively enlarge. In the wing, over-
expression of one copy of the PAT gene also en-
hances growth, primarily through increased cell
proliferation, but two copies reduce it. Similarly,
using cultured HEK293 cells, modest human PAT1
overexpression in a stable cell line (PAT [) in-
creases mTORC1 signaling and cell proliferation;
however, signaling and proliferation decrease with
transient (high level) expression, probably through
a dominant-negative mechanism.
(B) PAT overexpression in the fly eye leads to
a mild, but measurable, increase in growth
(b versus a), in contrast to loss of PTEN, a PI3K
antagonist, which has a pronounced growth-
stimulatory effect, disturbing the hexagonal
array of ommatidia (d). Increased PI3K signal-
ing significantly enhances PAT-induced growth
(e versus b), promoting intracellular localization of
a GFP-tagged PAT: GFP-PAT is marked at the cell
surface (white arrow) and inside (yellow arrow)
larval fat body cells (f versus c; images from O¨g-
mundsdo´ttir et al., 2012). Scale bar, 100 mm (a, b,
d, and e) and 20 mm (c and f).
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tility of LELs as amino acid sensing hubs is well illustrated by
the cellular response to starvation. Reduced mTORC1 signaling
induces degradation of endocytosed extracellular proteins (Palm
et al., 2015; Pavlova and Thompson, 2016) and autophagy,
driving breakdown of cellular proteins via autolysosome forma-
tion (Yu et al., 2010; Carroll et al., 2015): the free amino acids pro-
duced are critical in maintaining or restoring mTORC1 activity.
While amino acid transporters potentially provide a direct link
between LEL luminal amino acids andmTORC1 activation, cyto-
solic amino acids have also been implicated in the activation pro-
cess (Figure 2) and may play an important and complementary
role in amino acid sensing. Leucyl-tRNA synthetase (LRS) may
act as a leucine sensor that switches on RagD (Han et al.,
2012). Cytosolic folliculin (FLCN) and interacting protein, FNIP,mediate activation of RagC and RagD by
amino acids by acting as a GTPase-acti-
vating complex that converts the Rags
into their functionally active GDP-bound
forms (Tsun et al., 2013). Furthermore,
Sestrin 2, a member of the Sestrin family
of proteins, which activate RagA and
RagB either directly or indirectly via
GATOR2 (reviewed in Shimobayashi and
Hall, 2016), also senses leucine (Wolfson
et al., 2016). Recently, a vertebrate-spe-
cific protein, CASTOR1 (or GATS-like pro-
tein 3), has been reported as a cytosolic
arginine sensor, which blocks GATOR2
function in the absence of arginine (Chan-
tranupong et al., 2016).
Aside from these molecules that
directly interact with amino acids to con-trol mTORC1 activity, several other proteins have been impli-
cated in the amino acid sensing process and are briefly reviewed
below. Some are of particular interest because they may involve
subcellular compartments other than LELs and therefore are
consistent with a multi-hub model for mTORC1 control.
Alternative Sensing Mechanisms
TheMAP kinase regulator MAP4K3was shown to be required for
amino-acid-dependent mTORC1 signaling using HEK293T and
HeLa cells (Findlay et al., 2007). This function is conserved in
Drosophila and appears to involve interactions with the Rag
GTPases (Bryk et al., 2010). The Class III PI3-kinase, Vps34,
which catalyzes the synthesis of the lipid, phosphatidylinositol
(3)-phosphate, an important regulator of endocytosis and auto-
phagy, was identified as a potential mediator of mTORC1’sCell Metabolism 23, April 12, 2016 583
Figure 4. AminoAcid Transport and Sensing
(A) Amino acid transporters were originally classi-
fied by their ability to translocate specific groups
of amino acids across the lipid bilayer (left). How-
ever, some can activate amino-acid-dependent
signaling, either in the presence or absence of
transport. These so-called ‘‘transceptors’’ may be
the precursors to modern-day receptors (right).
Black arrows represent amino acid transport and
green arrows signal transmission.
(B) Amino acid (AA) transport has been studied
in vitro using Xenopus oocytes, facilitated by their
large size (1,000 mm diameter) and little back-
ground transport activity; in reconstituted proteo-
liposomes (up to 500 mm diameter); or in human
cells (20 mm diameter), which may contain
multiple endogenous transporters. Note that in
proteoliposomes, external medium may be topo-
logically equivalent to cytosolic side of lipid bilayer,
unlike the other two models.
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However, in this case, studies in flies did not suggest a role in
normal growth in vivo (Juha´sz et al., 2008).
Two important points can be concluded from these findings.
First, genetic manipulation of any molecule that interacts with
and/or modifies components of the LEL-localized mTORC1
supercomplex could modulate the amino acid sensing mecha-
nism. More elaborate experiments demonstrating direct amino
acid interaction are required to identify genuine amino acid
sensors. Second, when mTORC1 is regulated from the sur-
face of intracellular compartments within the secretory and
endolysosomal system, its activity will be heavily influenced
by changes in membrane trafficking and endolysosomal
maturation, themselves controlled by growth factor and
mTORC1 signaling (O¨gmundsdo´ttir et al., 2012; Zhang et al.,
2015). Developing better cell systems to analyze this intricate
regulatory interplay will be a critical objective in the coming
years.
Interestingly, the identification of two other molecules involved
in membrane trafficking as regulators of an alternative mTORC1
complex has recently provided evidence for amulti-hubmodel of
mTORC1 regulation. The first, Arf1, traditionally implicated in
Golgi transport, is involved in glutamine-dependent mTORC1
activation via a Rag-independent lysosomal mechanism in
mouse embryonic fibroblasts and HEK293A cells (Jewell et al.,584 Cell Metabolism 23, April 12, 2016(2015). The second, Rab1A, involved in
ER/Golgi trafficking, affects amino-acid-
dependent mTORC1 activation on the
Golgi, also in a Rag-independent fashion,
in HEK293E and mouse NIH 3T3 cells
(Thomas et al., 2014). Rab1A is overex-
pressed in colorectal cancer (Thomas
et al., 2014) and hepatocellular carci-
noma (Xu et al., 2015), suggesting
that like LEL-localized, Rag-dependent
mTORC1, this alternative mTORC1 com-
plex could be an important therapeutic
target. This poses the question of how
amino acids might be sensed from theGolgi apparatus, particularly since the characterized cytosolic
sensors discussed above all act via the Rags.
Amino Acid Sensing from the Golgi Apparatus
In addition to PAT1, the other widely expressed human PAT
transporter required for mTORC1 activation, PAT4 (SLC36A4;
Heublein et al., 2010; Matsui and Fukuda, 2013), has recently
been shown to be predominantly localized on the trans-
Golgi network in several cell types (Fan et al., 2015). In
HCT116 colorectal cancer cells, PAT4 regulates a form of
mTORC1 that appears to be resistant to the drug rapamycin
and seems to more strongly affect 4E-BP1 phosphorylation
than S6K, in contrast to rapamycin-sensitive mTORC1. High
PAT4 levels in colorectal cancer patients are associated with
poor prognosis after surgery. PAT4 interacts with Rab1A,
Raptor, and mTOR on the Golgi (Fan et al., 2015), as shown
by proximity ligation assay (PLA), which detects closely
apposed antigens in situ in whole-mount cells (Weibrecht
et al., 2010). These data support a model in which an mTORC1
signaling hub is assembled on the Golgi. The levels of PAT4
determine the resistance of mTORC1 to either glutamine or
serine starvation, two amino acids that are rapidly metabolized
in many cancer cells. It remains unclear whether there is any
functional relationship between PAT4-regulated mTORC1 and
the lysosomal form of Rag-independent, glutamine-sensitive,
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2015).
Additional Rab1A biochemical and PLA data support the exis-
tence of a Rag-independent, Golgi-localized form of mTORC1
(Thomas et al., 2014). The LELs are, therefore, not the only plat-
form for amino-acid-dependent mTORC1 signaling. The alterna-
tivemTORC1 signaling hubs potentially respond to different sub-
sets of amino acids or different subcellular cues. For example,
while LEL-located mTORC1 can detect extracellular-derived or
autophagic amino acids in the LEL lumen, Golgi-localized
mTORC1 could be controlled by amino acids trafficked back in
a retrograde fashion from the endosomal system or brought
into the Golgi lumen by Golgi-localized amino acid transporters.
Significantly, the different amino acid and target preferences of
specific mTORC1 hubs suggest distinct functions.
Although more studies are required to determine how different
mechanisms of amino acid sensing might work together to con-
trol the mTORC1 hubs, there is a common thread in the amino
acid transporter story. PAT (SLC36) and SLC38 transporter fam-
ilies are structurally related. The region of greatest homology is in
the 11 transmembrane domain core of the transporter, which in
SLC38A9 has been shown to interact specifically with compo-
nents of the mTORC1 supercomplex (Figure 2; Wang et al.,
2015), albeit with lower affinity than the N-terminal SLC38A9
domain. One explanation for the various, and sometimes
contradictory, findings from different groups studying trans-
porter-mediated sensing mechanisms is that the experimen-
tal approaches employed focus on different aspects of the
mTORC1 regulatory puzzle. Furthermore, depending on the
cell type or culture conditions employed, certain sensing mech-
anisms may dominate over others. There are in fact unanswered
questions relating to all the mechanisms proposed to date.
Consideration of how each study approaches the problem could
help piece together the puzzle in a more integrated way.
Amino Acid Sensing: The Experimental Challenges
Although for some years leucine was highlighted as the key
amino acid in mTORC1 regulation (Christie et al., 2002), other
important amino acids have since been implicated. In some
cases, these amino acids promote cellular leucine uptake
(Nicklin et al., 2009), but in others, they more directly influence
mTORC1 activity. What led to the emergence of these multiple
sensing mechanisms?
One factor is that different cell types, particularly cancer cells,
metabolize amino acids differently, so that even nonessential
amino acids, like serine or glutamine, become limiting upon star-
vation (Maddocks et al., 2013; Jewell et al., 2015; Fan et al.,
2015). Some studies have by design, or inadvertently, tended
to focus on a specific starvation regime or one mTORC1-regula-
tory amino acid transporter with distinct amino acid specificity,
thereby probing only one sensing mechanism. Moreover, in
many cancer cell lines, oncogenic pathways may selectively
affect the activity of specific sensing pathways; this is illustrated
by the effect of PI3K on PAT-induced growth in vivo (Figure 3B;
O¨gmundsdo´ttir et al., 2012).
Approaches for studying amino acid sensitivity also differ.
Cells are often starved of amino acids and serum, and then spe-
cific amino acids are added back, or alternatively one amino acid
is removed in the absence of serum (Sancak et al., 2008). Othergroups have used dialyzed serum to mirror physiological condi-
tions more closely (Averous et al., 2014; Guenther et al., 2014).
These types of starvation experiments highlight requirements
for particular amino acids but do not clarify whether mTORC1
is sensing different levels of specific amino acids or merely re-
sponding to amino acid presence or absence. This point can
be addressed by varying sensor and amino acid concentrations
(Fan et al., 2015). One important point is that although a fewmol-
ecules involved in amino acid sensing have been tested in
different models such as mice or flies (e.g., Kim et al., 2008;
Efeyan et al., 2014; Goberdhan et al., 2005), most have not.
Therefore, the physiological relevance of cell-culture starvation
experiments remains uncertain when organisms employmultiple
homeostatic mechanisms in vivo to maintain extracellular amino
acid levels.
For those amino acid transporters that act as sensors for
mTORC1, an important question has been whether they interact
with the amino acid(s) that they are believed to sense. Current
assays often rely on measuring amino acid transport into Xeno-
pus oocytes or proteoliposomes. In the transceptor signaling
model for mTORC1 regulation (Figure 4A), however, even amino
acids that compete with substrates, but are not transported, are
potential regulators. The known substrates of PAT1, proline and
glycine, which have been implicated in cancer growth and meta-
bolic control (Liu et al., 2015; Labuschagne et al., 2014; Li and
Zhang, 2015), may therefore be sensed by this transporter
(Figure 2), or other competing amino acids could be involved.
In addition, neither the oocyte plasma membrane nor a proteoli-
posome (Figure 4B) mirrors the complex limiting membranes of
LELs or Golgi, making it difficult to be certain that amino acid
specificities observed are biologically significant. Amino acid af-
finities are typically calculated by labeling external amino acids.
While the medium around an oocyte may be topologically equiv-
alent to the LEL/Golgi lumen, the proposed site for sensing, it can
represent the cytosolic side in proteoliposomes (Figure 4B;
Wang et al., 2015; Rebsamen et al., 2015) and potentially provide
a very different affinity profile.
The methodologies employed to demonstrate that amino
acid transporters are functioning within an active mTORC1-
regulatory complex influence the resulting conclusions. Coim-
munoprecipitation data defined components of the mTORC1
supercomplex on LELs (e.g., Zoncu et al., 2011; Wang et al.,
2015) but relied on the membrane complex involved remaining
stably associated during the pull-down procedure. The PLA
approach highlights less stable interactions in situ but can detect
molecules separated by up to 40 nm, potentially identifying
nearby proteins that are not part of a single complex. mTOR
recruitment to LELs has been used as a simple assay for
amino-acid-dependent activation. However, it concentrates at
the surface of LELs independently of amino acids in the absence
of SLC38A9 (Rebsamen et al., 2015; Jung et al., 2015). This sug-
gests that the factors affecting recruitment are more complex
than current models indicate.
Amino acid transporter overexpression has been used as a
complementary approach to knockdown to demonstrate func-
tional roles in mTORC1 activation. But the results need careful
interpretation. For example, SLC38A9 overexpression makes
mTORC1 signaling amino acid insensitive (Wang et al., 2015; Re-
bsamen et al., 2015). On the other hand, overexpression ofCell Metabolism 23, April 12, 2016 585
Figure 5. Intracellular Amino Acid
Transporters and Multi-Hub mTORC1
Regulation
Schematic model in which amino acid transporters
(red wavy lines) act as integral components of
multiple intracellular sensing supercomplexes
(pink spots). These transporters sense the amino
acid content of different subcellular compart-
ments, acting in conjunction with cytosolic amino
acid sensors to control the activity of specific
mTORC1 hubs (green). They appear to respond to
the specific amino acids indicated. Other trans-
porters act as conduits (blue rectangles) bringing
amino acids into specific compartments: for the
plasma membrane, CD98 coupled with SLC1A5;
and for LELs, the LAPTM4b-associated CD98
heterodimer. Equivalent conduit-like transporters
for the Golgi are not yet identified. Unlike the
SLC38A9- and PAT1-regulated LEL-localized
sensing complexes, mTORC1 hubs controlled by
ARF1 and Rab1A/PAT4 appear to be Rag inde-
pendent and are therefore not under the control of
the cytosolic sensors shown in Figure 2. ARF1 is
typically found on Golgi membranes but is re-
ported to control a lysosomal sensing complex.
Reactive oxygen species (ROS)-activated, perox-
isome-bound TSC blocks activation of mTORC1,
but how this message is relayed remains unclear.
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and in culture (Goberdhan et al., 2005; Heublein et al., 2010) or
may, when expression levels are raised further, inhibit these
processes, presumably via a dominant-negative mechanism
(Figure 3A; Goberdhan et al., 2005; Zoncu et al., 2011).
These issues highlight the importance of using a range of
experimental approaches when dissecting out the mechanisms
of transporter-mediated amino acid sensing, particularly when
considering a multi-hub model for mTORC1 control.
New Perspective: Multiple Hubs to Integrate Different
Amino Acid Inputs
As discussed above, in vivo and cell-culture evidence strongly
implicates multiple intracellular amino acid transporters in deter-586 Cell Metabolism 23, April 12, 2016mining the amino acid sensitivity of
mTORC1. Equally important, recent find-
ings encourage thinking beyond a model
where a single mTORC1 hub acts from
the LELs to control metabolism and
growth. Instead, mTORC1 should be
considered as providing a sensory
readout from more than one subcellular
compartment with varying sensitivity to
amino acids, potentially leading to
different outputs (Figure 5).
This view complements and extends
findings suggesting that additional
mTORC1 signaling inputs may also be
sensing metabolically important changes
in other subcellular compartments
(Benjamin and Hall, 2013). For example,
buildup of reactive oxygen species
(ROS) in peroxisomes appears to nega-
tively regulate mTORC1 via activation ofa peroxisome-associated TSC complex, ultimately promoting
autophagy (Figure 5; Zhang et al., 2013). In the multi-hub model,
the proposal that the amino acid microenvironment inside spe-
cific subcellular compartments could provide different readouts
of a cell’s metabolic state, to which specific mTORC1 hubs
respond, introduces a new layer of complexity to mTORC1 con-
trol and function. However, at present, except in the case of
LELs, we have very limited understanding of how amino acids
might accumulate inside different mTORC1-regulatory compart-
ments and whether as yet unidentified compartmentalized
amino acid transporters, like CD98 on lysosomes, might be
involved. Moreover, even for LEL-localized mTORC1, the picture
is complicated by the existence of transporter-independent
sensing mechanisms for cytosolic amino acids.
Cell Metabolism
PerspectiveThe concept of different mTORC1 complexes in a multi-hub
model having different target specificities, and therefore possibly
distinct cellular functions, flags up the importance of testing
multiple downstream targets in studying each sensing mecha-
nism. Given the roles of mTORC1 in normal metabolism, growth,
aging, and also pathological processes, such as neurodegener-
ation and cancer, such analysis should dissect out more special-
ized functions for particular amino-acid-sensing transporters
and possibly reveal selective effects of different amino acids,
amino acid analogs, andmTORC1 inhibitory drugs. For example,
rapamycin-resistant mTORC1 preferentially affects specific
mTORC1-dependent substrates and therefore potentially spe-
cific pathologies (Peterson et al., 2011; Fan et al., 2015). Ulti-
mately, the development of better in vivo systems will be
required to assess the physiological and disease relevance of
the alternative mTORC1 hubs (e.g., Shen et al., 2016). The use
of positron emission tomography (PET)-labeled amino acids,
specific inhibitors, and/or inducible knockdown of selective reg-
ulatorsmay be helpful in pursuing this goal. In this context, amino
acid transporters now offer a selective tool to unpick the multi-
hub mTORC1 model, providing new strategies for targeting of
this central metabolic pathway.
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